Lumos Pharma Inc Stock - LUMO Share Price Today, News and Discussion

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

29

Current Price	$3.53
Prev Close	$3.40
Open	$3.61
Dividend Yield	0.00%
50-Day Moving Average	$3.92
Beta	0.85
Avg. Volume	15,351.55
PE Ratio	N/A

52-Week High	$10.27
52-Week Low	$2.95
Market Capitalization	$29.15M
EPS	-$3.40
Price to Book	0.43
Revenue Per Employee	$42,448.28
Enterprise Value/EBITDA	-0.23

No LUMO news at the moment.

LUMO Lumos Pharma Inc

About

Feed

Fundamentals

News